IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US-10188659-B2 · Jan 29, 2019 · US
This page is not indexed by search engines while we improve data quality.
Levitzki Alexander patents
Levitzki Alexander is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Levitzki Alexander |
| Total patents | 6 |
| First publication | Jul 7, 2015 |
| Latest publication | Jan 29, 2019 |
Notable patents
Publications ranked by popularity score, then publication date.
Igf-1r signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US-2018064725-A1 · Mar 8, 2018 · US
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US-9770454-B2 · Sep 26, 2017 · US
Igf-1r signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US-2016158243-A1 · Jun 9, 2016 · US
Compounds for treatment of cell proliferative diseases
US-9096499-B2 · Aug 4, 2015 · US
2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of cancer
US-9073880-B2 · Jul 7, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Yissum Res Dev Co | 3 |
| Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | 2 |
| Reuveni Hadas | 1 |
| Levitzki Alexander | 1 |
| Univ Texas | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/5415 | 5 |
| C07D279/08 | 5 |
| A61P25/28 | 4 |
| A61K31/165 | 4 |
| A61P25/00 | 4 |